Tau protein levels in the cerebrospinal fluid of the patients with multiple sclerosis in an attack period: Low levels of tau protein may have significance, too


Kosehasanogullari G., ÖZAKBAŞ S., Idiman E.

CLINICAL NEUROLOGY AND NEUROSURGERY, vol.136, pp.107-109, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 136
  • Publication Date: 2015
  • Doi Number: 10.1016/j.clineuro.2015.05.030
  • Journal Name: CLINICAL NEUROLOGY AND NEUROSURGERY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.107-109
  • Keywords: Multiple sclerosis, Cerebrospinal fluid, Tau protein, AXONAL DEGENERATION, DIAGNOSTIC-CRITERIA, BIOLOGICAL MARKERS, CSF, DISEASE, DAMAGE, BLOOD, PROGRESSION, BIOMARKERS, DISABILITY
  • Dokuz Eylül University Affiliated: Yes

Abstract

Objectives: Axonal loss is the cause of permanent neurologic disability in patients with MS. There are a lot of candidates to be a surrogate biological marker of the axonal loss in MS including tau protein. In the present study, we aimed to assess the levels of the tau protein in patients with MS, and in neurologically healthy controls.